Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$758,921
+$359,679 QoQ
Shares Held
5,906
+77.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2,342
of 3,769 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Revisor Wealth Management LLC holds $7,877,632 across 8 Drug Manufacturers - General names. MRK ranks #6 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
30,786 | $1,613,802 | |
| 2 | JNJ |
Johnson & Johnson
|
5,622 | $1,427,819 | |
| 3 | AMGN |
Amgen Inc
|
3,075 | $1,113,519 | |
| 4 | ABBV |
AbbVie Inc.
|
3,399 | $855,324 | |
| 5 | LLY |
ELI LILLY & Co
|
712 | $853,994 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
5,906 | $758,921 | |
| 7 | PFE |
Pfizer Inc
|
30,193 | $727,047 | |
| 8 | NVS |
Novartis AG
|
3,364 | $527,206 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $758,921 | 5,906 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $399,242 | 3,319 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $343,252 | 3,261 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $266,393 | 3,174 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $240,250 | 3,035 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $325,200 | 3,623 | Shares | Sole | 2025-04-28 | |
| 2024-09-30 | $249,718 | 2,199 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $222,344 | 1,796 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $439,525 | 3,331 | Shares | Sole | 2024-04-23 | |
| 2023-09-30 | $229,269 | 2,227 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $203,894 | 1,767 | Shares | Sole | 2023-11-21 | |
| No filing history on record for this holder in this stock. | ||||||